KLK3/PSA Monoclonal antibody

KLK3/PSA Monoclonal Antibody for WB, IHC, ELISA
Cat No. 60338-1-Ig

产品说明书

CloneNo. 4A1E2

宿主/亚型

Mouse / IgG1

种属反应性

human

应用

WB, IHC, ELISA

KLK3, 4A1E2, APS, EC:3.4.21.77, Gamma-seminoprotein

缓冲液配方:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
PBS Only
偶联物:  Unconjugated
Unconjugated
规格价格库存


经过测试的应用

Positive WB detected inLNCaP cells
Positive IHC detected inhuman prostate cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Planning an IHC experiment? We recommend our IHCeasy PSA Ready-To-Use IHC Kit. PSA primary antibody included.

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:1000-1:4000
Immunohistochemistry (IHC)IHC : 1:5000-1:20000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

发表文章中的应用

WBSee 6 publications below

产品信息

60338-1-Ig targets KLK3/PSA in WB, IHC, ELISA applications and shows reactivity with human samples.

经测试应用 WB, IHC, ELISA Application Description
文献引用应用WB
经测试反应性 human
文献引用反应性human
免疫原

CatNo: Ag1060

Product name: Recombinant human KLK3,PSA protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-261 aa of BC005307

Sequence: MWVPVVFLTLSVTWIGAAPLILSRIVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCIRNKSVILLGRHSLFHPEDTGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKVMDLPTQEPALGTTCYASGWGSIEPEEFLTPKKLQCVDLHVISNDVCAQVHPQKVTKFMLCAGRWTGGKSTCSGDSGGPLVCNGVLQGITSWGSEPCALPERPSLYTKVVHYRKWIKDTIVANP

种属同源性预测
宿主/亚型 Mouse / IgG1
抗体类别 Monoclonal
产品类型 Antibody
全称 kallikrein-related peptidase 3
别名 KLK3, 4A1E2, APS, EC:3.4.21.77, Gamma-seminoprotein
计算分子量 29 kDa
观测分子量 30-34 kDa
GenBank蛋白编号BC005307
基因名称 KLK3
Gene ID (NCBI) 354
RRIDAB_2881447
偶联类型 Unconjugated
形式Liquid
纯化方式Protein G purification
UNIPROT IDP07288
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

KLK3 also known as Prostate-Specific Antigen (PSA), is a 33 kDa glycoprotein primarily synthesized by the epithelial cells of the prostate gland. Its main physiological function is to cleave seminogelins I and II in semen, leading to the liquefaction of the seminal coagulum and the release of motile sperm. It is under tight regulation by androgens via the androgen receptor (AR). Serum PSA levels are elevated in prostate cancer due to disruption of the glandular architecture, allowing more PSA to enter the bloodstream. It is used alongside digital rectal exam (DRE) for early detection. Although termed "prostate-specific," PSA is not exclusively produced by the prostate. Very low levels can be produced in periurethral glands, breast tissue, and some other tissues. Its expression is highly abundant in prostatic tissue and seminal fluid.

实验方案

Product Specific Protocols
IHC protocol for KLK3/PSA antibody 60338-1-IgDownload protocol
WB protocol for KLK3/PSA antibody 60338-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

发表文章

SpeciesApplicationTitle
humanWB

Cell Death Dis

N-glycosylation of GDF15 abolishes its inhibitory effect on EGFR in AR inhibitor-resistant prostate cancer cells

Authors - Rong Wang
humanWB

J Cell Commun Signal

Estrogens drive the endoplasmic reticulum-associated degradation and promote proto-oncogene c-Myc expression in prostate cancer cells by androgen receptor/estrogen receptor signaling

Authors - Yalcin Erzurumlu
humanWB

Cell Signal

1,25(OH)2 D3 induced vitamin D receptor signaling negatively regulates endoplasmic reticulum-associated degradation (ERAD) and androgen receptor signaling in human prostate cancer cells

Authors - Yalcin Erzurumlu
humanWB

J Nat Med

Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells

Authors - Yalcin Erzurumlu
humanWB

Cell Signal

Triiodothyronine positively regulates endoplasmic reticulum-associated degradation (ERAD) and promotes androgenic signaling in androgen-dependent prostate cancer cells

Authors - Yalcin Erzurumlu
humanWB

ACS Appl Mater Interfaces

Two-in-One Polymeric NO-Donor Prodrugs Mediate Precision and Synergistic Prostate Cancer Treatment

Authors - Bingbing Zhao
Loading...
||
New chat Able
正在加载,请稍候...